Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2010 3
2011 1
2012 2
2013 2
2014 2
2017 2
2018 4
2019 6
2020 8
2021 5
2022 10
2023 8

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Seven classes of antiviral agents.
Ianevski A, Ahmad S, Anunnitipat K, Oksenych V, Zusinaite E, Tenson T, Bjørås M, Kainov DE. Ianevski A, et al. Among authors: oksenych v. Cell Mol Life Sci. 2022 Nov 27;79(12):605. doi: 10.1007/s00018-022-04635-1. Cell Mol Life Sci. 2022. PMID: 36436108 Free PMC article. Review.
DNA Damage Response.
Oksenych V, Kainov DE. Oksenych V, et al. Biomolecules. 2021 Jan 19;11(1):123. doi: 10.3390/biom11010123. Biomolecules. 2021. PMID: 33477863 Free PMC article.
DNA Repair and Immune Response: Editorial.
Oksenych V. Oksenych V. Biomolecules. 2022 Dec 30;13(1):84. doi: 10.3390/biom13010084. Biomolecules. 2022. PMID: 36671469 Free PMC article.
Novel Synergistic Anti-Enteroviral Drug Combinations.
Ianevski A, Zusinaite E, Tenson T, Oksenych V, Wang W, Afset JE, Bjørås M, Kainov DE. Ianevski A, et al. Among authors: oksenych v. Viruses. 2022 Aug 25;14(9):1866. doi: 10.3390/v14091866. Viruses. 2022. PMID: 36146673 Free PMC article.
Novel activities of safe-in-human broad-spectrum antiviral agents.
Ianevski A, Zusinaite E, Kuivanen S, Strand M, Lysvand H, Teppor M, Kakkola L, Paavilainen H, Laajala M, Kallio-Kokko H, Valkonen M, Kantele A, Telling K, Lutsar I, Letjuka P, Metelitsa N, Oksenych V, Bjørås M, Nordbø SA, Dumpis U, Vitkauskiene A, Öhrmalm C, Bondeson K, Bergqvist A, Aittokallio T, Cox RJ, Evander M, Hukkanen V, Marjomaki V, Julkunen I, Vapalahti O, Tenson T, Merits A, Kainov D. Ianevski A, et al. Among authors: oksenych v. Antiviral Res. 2018 Jun;154:174-182. doi: 10.1016/j.antiviral.2018.04.016. Epub 2018 Apr 23. Antiviral Res. 2018. PMID: 29698664 Free PMC article. Review.
Discovery and development of safe-in-man broad-spectrum antiviral agents.
Andersen PI, Ianevski A, Lysvand H, Vitkauskiene A, Oksenych V, Bjørås M, Telling K, Lutsar I, Dumpis U, Irie Y, Tenson T, Kantele A, Kainov DE. Andersen PI, et al. Among authors: oksenych v. Int J Infect Dis. 2020 Apr;93:268-276. doi: 10.1016/j.ijid.2020.02.018. Epub 2020 Feb 17. Int J Infect Dis. 2020. PMID: 32081774 Free PMC article. Review.
Mono- and combinational drug therapies for global viral pandemic preparedness.
Ianevski A, Yao R, Simonsen RM, Myhre V, Ravlo E, Kaynova GD, Zusinaite E, White JM, Polyak SJ, Oksenych V, Windisch MP, Pan Q, Lastauskienė E, Vitkauskienė A, Matukevičius A, Tenson T, Bjørås M, Kainov DE. Ianevski A, et al. Among authors: oksenych v. iScience. 2022 Mar 17;25(4):104112. doi: 10.1016/j.isci.2022.104112. eCollection 2022 Apr 15. iScience. 2022. PMID: 35402870 Free PMC article. Review.
54 results